Critical Assessment in Routine Clinical Practice of Liquid Biopsy for EGFR Status Testing in Non-Small-Cell Lung Cancer: A Single-Laboratory Experience (LPCE, Nice, France).

Simon Heeke,Jonathan Benzaquen,Véronique Hofman,Marius Ilié,Maryline Allegra,Elodie Long-Mira,Sandra Lassalle,Virginie Tanga, Carole Salacroup,Christelle Bonnetaud,Julien Fayada, Loïc Gazoppi, Lydia Ribeyre,Olivier Castelnau, Georges Garnier,Florian Cattet,Isabelle Nanni,Florence de Fraipont,Charlotte Cohen,Jean-Philippe Berthet,Sylvie Leroy,Michel Poudenx,Charles Hugo Marquette,Marc G Denis,Fabrice Barlesi,Paul Hofman

Clinical Lung Cancer（2020）

引用 23|浏览31

暂无评分

摘要

PCR-based assays are a fast and convenient test, allowing the detection of primary and secondary EGFR mutations from plasma. Cobas proved to be a reliable test, whereas digital PCR produced too many inconclusive results to be currently recommended as a principal testing device.

查看译文

关键词

Afatinib,Erlotinib,Gefitinib,Non-invasive assay,Osimertinib

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要